The revenue stands at ₹2,392.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.42 per cent from ₹2,556.50 crore. This corresponds to a year-on-year *(YoY) growth of 6.55 per cent.
Operating Profit stands at ₹533.35 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.59 per cent from ₹486.66 crore. This corresponds to a year-on-year *(YoY) growth of 15.17 per cent.
PBDT stands at ₹553.19 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.45 per cent from ₹491.94 crore. This corresponds to a year-on-year *(YoY) growth of 18.86 per cent.
Profit Before Tax stands at ₹445.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.67 per cent from ₹388.61 crore. This corresponds to a year-on-year *(YoY) growth of 21.43 per cent.
Net Profit stands at ₹363.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.64 per cent from ₹280.53 crore. This represents a 31.59 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ipca Labs. | 1.08% | 0.21% | 6.33% | 8.48% | 16.89% | 11.79% |
| Abbott India | -0.51% | -0.72% | -2.36% | -7.57% | -12.16% | -16.07% |
| Anthem Bioscienc | -0.25% | -1.57% | 15.11% | 16.88% | 9.55% | 4.55% |
| Glaxosmi. Pharma | 1.43% | 0.32% | 1.36% | -4.31% | -8.18% | -16.26% |
| Ajanta Pharma | -0.87% | 2.55% | 4.95% | 0.85% | 13.89% | 15.12% |
| Emcure Pharma | -1.19% | 2.21% | 14.10% | 16.84% | 30.13% | 73.10% |
| J B Chemicals & | 0.47% | 1.32% | 7.07% | 12.95% | 22.83% | 39.03% |
Executive Chairman : Premchand Godha
Managing Director & CFO : A K Jain
Managing Director & Chief Executive Officer : Pranay Godha
Executive Director : Prashant Godha
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Narendra Mairpady
Company Sec. & Compli. Officer : Harish P Kamath
Independent Director : Swati Patankar
Independent Director : Vivek Shiralkar